Maintenance Therapy for First-Line Metastatic Colorectal Cancer: Activity and Sustainability

Por Strickler, John H., Hurwitz, Herbert I.
Publicado em 2012

Bevacizumab-Based Therapies in the First-Line Treatment of Metastatic Colorectal Cancer

Por Strickler, John H., Hurwitz, Herbert I.
Publicado em 2012

Anti-VEGF Therapies in the Clinic

Por Meadows, Kellen L., Hurwitz, Herbert I.
Publicado em 2012

Understanding and targeting resistance to anti-angiogenic therapies

Por Clarke, Jeffrey M., Hurwitz, Herbert I.
Publicado em 2013

An open-label study to determine the maximum tolerated dose of the multitargeted tyrosine kinase inhibitor CEP-11981 in patients with advanced cancer

Por Pili, Roberto, Carducci, Michael, Brown, Peter, Hurwitz, Herbert
Publicado no Invest New Drugs (2014)

A leave-one-out cross validation SAS macro for the identification of markers associated with survival

Por Rushing, Christel, Bulusu, Anuradha, Hurwitz, Herbert, Nixon, Andrew B., Pang, Herbert
Publicado no Comput Biol Med (2014)

Vascular Endothelial Growth Factor Receptor 2 (Vegfr2) Controls Blood Pressure by Regulating Nitric Oxide Synthase Expression

Por Facemire, Carie S., Nixon, Andrew B., Griffiths, Robert, Hurwitz, Herbert, Coffman, Thomas M.
Publicado em 2009

Adjuvant Hepatic Arterial Chemotherapy Following Metastasectomy in Patients With Isolated Liver Metastases

Por Onaitis, Mark, Morse, Michael, Hurwitz, Herbert, Cotton, Peggy, Tyler, Douglas, Clavien, Pierre, Clary, Bryan
Publicado em 2003

A Phase I, first-in-human, open label, dose escalation study of MGD007, a humanized gpA33 × CD3 dual-affinity re-targeting (DART(®)) protein in patients with relapsed/refractory me...

Por Hurwitz, Herbert, Crocenzi, Todd, Lohr, Joanna, Bonvini, Ezio, Johnson, Syd, Moore, Paul, Wigginton, Jon
Publicado no J Immunother Cancer (2014)

Effects of the combination of TRC105 and bevacizumab on endothelial cell biology

Por Liu, Yingmiao, Tian, Hongyu, Blobe, Gerard C., Theuer, Charles P., Hurwitz, Herbert I., Nixon, Andrew B.
Publicado em 2014

Partner-Assisted Emotional Disclosure for Patients with GI Cancer: Results from a Randomized Controlled Trial

Por Porter, Laura S., Keefe, Francis J., Baucom, Donald H., Hurwitz, Herbert, Moser, Barry, Patterson, Emily, Kim, Hong Jin
Publicado em 2009

Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies

Por Cassidy, James, Saltz, Leonard B., Giantonio, Bruce J., Kabbinavar, Fairooz F., Hurwitz, Herbert I., Rohr, Ulrich-Peter
Publicado em 2009

A Randomized, Phase II Trial of Standard Triweekly Compared with Dose-Dense Biweekly Capecitabine Plus Oxaliplatin Plus Bevacizumab as First-Line Treatment for Metastatic Colorecta...

Por Hurwitz, Herbert, Mitchell, Edith P., Cartwright, Thomas, Kwok, Ambrose, Hu, Sylvia, McKenna, Edward, Patt, Yehuda Z.
Publicado em 2012

Dual Inhibition of AlphaV Integrins and Src Kinase Activity as A Combination Therapy Strategy for Colorectal Cancer

Por Jia, Jingquan, Starodub, Alex, Cushman, Ian, Liu, Yingmiao, Marshall, Deborah J., Hurwitz, Herbert I., Nixon, Andrew B.
Publicado em 2013

Purpose and Benefits of Early Phase Cancer Trials: What Do Oncologists Say? What Do Patients Hear?

Por Kass, Nancy, Taylor, Holly, Fogarty, Linda, Sugarman, Jeremy, Goodman, Steven N., Goodwin-Landher, Annallys, Carducci, Michael, Hurwitz, Herbert
Publicado em 2008

Treatment of Palmar Plantar Erythrodysesthesia (PPE) with Topical Sildenafil: A Pilot Study

Por Meadows, Kellen L., Rushing, Christel, Honeycutt, Wanda, Latta, Kenneth, Howard, Leigh, Arrowood, Christy A., Niedzwiecki, Donna, Hurwitz, Herbert I.
Publicado no Support Care Cancer (2014)

Efficacy and Safety of Bevacizumab in Metastatic Colorectal Cancer: Pooled Analysis From Seven Randomized Controlled Trials

Por Hurwitz, Herbert I., Tebbutt, Niall C., Kabbinavar, Fairooz, Giantonio, Bruce J., Guan, Zhong-Zhen, Mitchell, Lada, Waterkamp, Daniel, Tabernero, Josep
Publicado em 2013

Analysis of Early Hypertension and Clinical Outcome With Bevacizumab: Results From Seven Phase III Studies

Por Hurwitz, Herbert I., Douglas, Pamela S., Middleton, John P., Sledge, George W., Johnson, David H., Reardon, David A., Chen, Dafeng, Rosen, Oliver
Publicado em 2013

Percutaneous biliary drainage catheter insertion in patients with extensive hepatic metastatic tumor burden

Por Langman, Eun L., Suhocki, Paul V., Hurwitz, Herbert I., Morse, Michael A., Burbridge, Rebecca A., Smith, Tony P., Kim, Charles Y.
Publicado no J Gastrointest Oncol (2016)

Correlation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumab

Por Liu, Yingmiao, Starr, Mark D, Bulusu, Anuradha, Pang, Herbert, Wong, Nan Soon, Honeycutt, Wanda, Amara, Anthony, Hurwitz, Herbert I, Nixon, Andrew B
Publicado em 2013